Plasma lipid peroxides (malondialdehyde) and thiols were measured in 45 patients with congestive heart failure and 45 controls. Malondialdehyde concentrations were significantly higher in the patients with congestive heart failure (median 9 0 nmol/ml interquartile range (IQR) 7-9-10-2) than in the controls (median 7-7 nmol/ml (IQR 6 9-9 2)).
There was a significant but weak negative correlation between malondialdehyde and left ventricular ejection fraction (r = -035) and a positive correlation between plasma thiols and left ventricular ejection fraction (r = 0-39).
This study provides clinical support for experimental data indicating that free radicals may be important in heart failure. It also suggests that the degree of free radical production may be linked to the severity of the disease.
in production of prostaglandins. The formation of prostaglandins is associated with the production of oxygen derived free radicals through the arachidonic acid pathway.8 Furthermore, circulating catecholamine production increases in the failing heart and their auto-oxidation generates free radicals. 9 There is therefore some evidence to suggest an involvement of free radicals in congestive heart failure.
We measured the products of free radical reactions in patients with congestive heart failure. The inherent reactivity of radical species with organic biomolecules precludes their direct measurement in biological systems. Their presence has to be inferred from their known effects, such as the induction of protein fluorescence and oxidation of polyunsaturated fatty acids. Two such systems, the measurement of lipid peroxides by the thiobarbituric acid test'0 and the measure of plasma thiols," have been carried out here and correlated with the left ventricular ejection fraction-a measure of the severity of congestive heart failure.
In congestive heart failure the heart is unable to provide sufficient blood for tissue metabolic needs. Congestive heart failure affects about 1% of the population' and carries a poor prognosis with an annual mortality of between 35% and 58%.2 The pathophysiology of this disorder is undoubtedly multifactorial but the cellular mechanisms at the molecular level have not been fully elucidated.
Oxygen free radicals have been implicated in cardiac ischaemic injury.34 These free radicals (superoxide anions and hydroxyl radicals) are produced in the body by reduction of oxygen. In normal circumstances they are removed by the different scavenger systems present in blood and tissue. We believe that free radicals are involved in the genesis of heart failure. In congestive heart failure myocardial contractility is impaired by loss of muscle or by pressure or volume overload.5 This pressure and volume overload causes myocardial ischaemia which can generate free radicals."4 Support for this hypothesis comes from work in animal models of heart failure where doxorubicin toxicity may result from myocardial injury induced by oxidative damage.6 Furthermore, it has been shown that polymorphonuclear leucocytes from dogs with congestive heart failure produce increased amounts of free radicals.7 In humans congestive heart failure is associated with an increase Patients and methods We studied 45 patients aged under 75 with congestive heart failure diagnosed by a team of hospital physicians. Most patients were thought to have atherosclerosis as the underlying cause of their congestive heart failure. All patients gave informed consent for the study and the study was approved by the hospital ethics committee. Patients with other disorders or receiving medication known to affect free radical activity were excluded from the study. No adjustment was made to the patient's medication, which was taken as usual on the day of the study. Results obtained were compared with 45 age, sex, and smoking matched controls.
The left ventricular ejection fraction was measured in the patients with Ellman."
Results
The table shows the comparability of the patients with congestive heart failure and the controls. There was no difference between the two groups (X 2 test). Figure 1 shows the concentration (median (IQR)) of malondialdehyde-like material in both the control population and in patients with congestive heart failure (7 7 (6&9-9 2) v 9 (7-9-10 2) nmol/ml). The patients with congestive heart failure had significantly higher con- fi The decrease in cellular pH durini will lead to formation of prostaglandins and leukotrienes. During their synthesis free radicals will be produced.8 Leukotriene B4 will further activate the polymorphonuclear leucocytes and increase secretion of neutrophil * free radicals. 20 The compensatory mechanism of an increase in catecholamines in congestive heart failure also increases free radicals.9 Free radicals themselves depress Ca2" binding and uptake into sarcoplasmic reticulum21; this 45 60 would lead to a decrease in cardiac contractility. Thus it is likely that free radicals actively promote the progression of congestive heart failure. Most of our patients had atherorith conges-sclerosis underlying their congestive heart was a sig-failure and the above mechanisms will coni left ven-tribute to the abnormalities detected. It would one of the be of interest to study patients with congestive estive heart heart failure secondary to conditions such as a Ae reactive cardiomyopathy to see whether free radical he course of products are also increased. n unpaired
The development of treatments to reduce or radicals is prevent radical induced tissue injury may ause they therefore be useful in congestive heart failure. I adjacent There are two major classes of antioxidant: initiate tis-preventative antioxidants (for example, re they are catalase, glutathione peroxidase, caeruloplasvity of free min) and chain-breaking (radical-trapping) urement in antioxidants (for example, vitamin E, vitamin iplex tech-C, reduced glutathione). Certain compounds e inferred, can be classified as both preventative and chainch as oxida-breaking antioxidants because they have both ds. This is functions (for example, superoxide dismutase, test which ,B carotene). The angiotensin converting peroxidised enzyme inhibitor, captopril, a well established advances in drug used in the treatment of congestive heart erformance failure, contains a sulphydryl group. Because nsitive and one of the effects of sulphydryl-containing dehyde-like compounds is to scavenge free radicals, capvas already topril may be a free radical scavenger. We have lance liquid confirmed this both in vitro22 and in humans.23 ited in our We showed that patients with congestive lo reason to heart failure have evidence of increased free have been radical activity that correlates with the left ntrations of ventricular ejection fraction, a measure of heart rd with the function linked to prognosis. It is likely that iat freezing congestive heart failure causes myocardial ery variable ischaemia with free radical production. Free mmediately radicals cause myocyte dysfunction, exacerbateduced the ing the impaired cardiac function and a vicious hotometric cycle is set in motion with the net result that a measured cardiac function steadily deteriorates. Some he presence drugs used in the treatment of congestive heart lation of the failure may be effective scavengers and such ,S.1718 The treatments should be further investigated. 
